scholarly journals Long-Term Survival After Allogeneic Haematopoietic Cell Transplantation for Acute Myeloid Leukemia. Comparable Results From Myeloablative and Non-Myeloablative Conditioning in Young and Elderly Patients

2013 ◽  
Vol 19 (2) ◽  
pp. S305-S306
Author(s):  
Henrik Sengelov ◽  
Thomas Gerds ◽  
Peter Braendstrup ◽  
Brian Kornblit ◽  
Bo Kok Mortensen ◽  
...  
Keyword(s):  
Acute Myeloid Leukemia ◽  
Elderly Patients ◽  
Cell Transplantation ◽  
Myeloid Leukemia ◽  
Myeloablative Conditioning ◽  
Term Survival ◽  
Haematopoietic Cell ◽  
Allogeneic Haematopoietic Cell Transplantation ◽  
Acute Myeloid

Long-term survival after induction therapy with idarubicin and cytosine arabinoside for de novo acute myeloid leukemia

2000 ◽  
Vol 79 (10) ◽  
pp. 533-542 ◽  
Author(s):  
M. Flasshove ◽  
P. Meusers ◽  
J. Schütte ◽  
R. Noppeney ◽  
D. W. Beelen ◽  
...  
Keyword(s):  
Acute Myeloid Leukemia ◽  
Induction Therapy ◽  
Cytosine Arabinoside ◽  
Myeloid Leukemia ◽  
De Novo ◽  
Term Survival ◽  
Long Term Survival ◽  
Acute Myeloid

scholarly journals Factors Affecting Long-Term Survival in Acute Myeloid Leukemia

2020 ◽  
pp. 1-2
Author(s):  
Yi-Qian ZHU ◽  
CHEN Bao-An ◽  
Cheng Jian ◽  
Yi-Qian ZHU
Keyword(s):  
Acute Myeloid Leukemia ◽  
Myeloid Leukemia ◽  
Remission Rate ◽  
Term Survival ◽  
Long Term Survival ◽  
Factors Affecting ◽  
Chemotherapy Drugs ◽  
Common Malignancy ◽  
Acute Myeloid

Acute myeloid leukemia (AML) is a common malignancy of the blood system, and most patients are so ill that they often die if they are untreated in time. In recent years, with the improvement of chemotherapy drugs and methods, the complete remission rate has been significantly improved, but the long-term survival rate still has great room for improvement. This review summarized the influencing factors related to the long-term survival of AML patients through reading and sorting out multiple pieces of literature.

Sign in / Sign up

Export Citation Format

Share Document